Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

The medicines watchdog has issued an urgent warning about a deluge of social media advertisements for counterfeit weight-loss ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 medications to support her weight loss goal. After six months on Wegovy ...

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

Ever since blockbuster weight-loss drugs like Wegovy and Zepbound went mainstream, calls to local poison control centers ...

(MENAFN- Mid-East Info) Participants achieved an average weight loss of 20.2% with ... least one weight-related medical problem and without diabetes. At 72 weeks, tirzepatide met the primary ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs ... s Comprehensive Weight Control Center. While both drugs are GLP-1 receptor agonists ...

Perspective from Sangeeta Kashyap, MD Tirzepatide conferred significantly greater weight loss than semaglutide ... findings from a real-world electronic medical record study found adults with ...

A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide, reshaping obesity treatment strategies and offering new hope for patients ...